Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Celecoxib on Heterotopic Bone Formation Following Cementless Total Hip Arthroplasty

NCT05648916 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT05648916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05648916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Celecoxib on Heterotopic Bone Formation Following Cementless Total Hip Arthroplasty
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Observational
Overall status
Unknown status
Start date
August 2, 2022
Completion date
August 31, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heterotopic ossification